Firestone W M, FitzGerald G B, Wick M M
Division of Medicine, Dana-Farber Cancer Institute, Boston, MA 02115.
J Invest Dermatol. 1990 May;94(5):657-61. doi: 10.1111/1523-1747.ep12876228.
The pharmacologic responses of normal and malignant epidermal cells to chemotherapeutic agents were examined in a system which consists of a serum-free "defined" medium. The effects of methotrexate (MTX), fluorodeoxyuridine (FUDR), and hydroxyurea upon cell growth, DNA synthesis, thymidylate synthase activity, and dihydrofolate reductase (DHFR) activity were compared in normal human epidermal keratinocytes (NHEK), newborn epidermal cells (NEC), human squamous cell carcinoma (SCC-25), and a methotrexate-resistant human squamous cell carcinoma (SCC-15R). Normal keratinocytes were found to be 10(3) to 10(4) times less sensitive to the effects of MTX and FUDR than the malignant cells with respect to growth and DNA synthesis. The differential sensitivity to MTX and FUDR was not due to differences in growth media, increased target enzyme activity, e.g., DHFR and thymidylate synthase, or impaired transport of these drugs. The results indicate that the mechanism for the increased sensitivity of the squamous cell carcinoma to MTX and FUDR must involve a process which is distal to the de novo synthesis of dTMP.
在一个由无血清“限定”培养基组成的系统中,研究了正常和恶性表皮细胞对化疗药物的药理反应。比较了甲氨蝶呤(MTX)、氟脱氧尿苷(FUDR)和羟基脲对正常人表皮角质形成细胞(NHEK)、新生儿表皮细胞(NEC)、人鳞状细胞癌(SCC - 25)以及耐甲氨蝶呤的人鳞状细胞癌(SCC - 15R)细胞生长、DNA合成、胸苷酸合成酶活性和二氢叶酸还原酶(DHFR)活性的影响。结果发现,就生长和DNA合成而言,正常角质形成细胞对MTX和FUDR作用的敏感性比恶性细胞低10³至10⁴倍。对MTX和FUDR的敏感性差异并非由于生长培养基的差异、靶酶活性增加(如DHFR和胸苷酸合成酶)或这些药物的转运受损。结果表明,鳞状细胞癌对MTX和FUDR敏感性增加的机制必定涉及一个位于dTMP从头合成下游的过程。